To prevent and control SARS outbreaks, several vaccine studies based on the spike protein of SARS have been done including S protein vaccine, fragment DNA vaccine, full-length DNA vaccines and receptor binding domain [17]. This evidence concerns the gene PROS1 and severe acute respiratory syndrome.